GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citi Pharma Ltd (KAR:CPHL) » Definitions » PB Ratio

Citi Pharma (KAR:CPHL) PB Ratio : (As of Apr. 18, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Citi Pharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-18), Citi Pharma's share price is ₨94.26. Citi Pharma's Book Value per Share for the fiscal year that ended in . 20 was ₨0.00. Hence, Citi Pharma's PB Ratio of today is .

The historical rank and industry rank for Citi Pharma's PB Ratio or its related term are showing as below:

KAR:CPHL's PB Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.84
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Citi Pharma PB Ratio Historical Data

The historical data trend for Citi Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citi Pharma PB Ratio Chart

Citi Pharma Annual Data
Trend
PB Ratio

Citi Pharma Semi-Annual Data
PB Ratio

Competitive Comparison of Citi Pharma's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Citi Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Citi Pharma's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Citi Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Citi Pharma's PB Ratio falls into.


;
;

Citi Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Citi Pharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (A: . 20)
=94.26/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Citi Pharma  (KAR:CPHL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Citi Pharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Citi Pharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Citi Pharma Business Description

Traded in Other Exchanges
N/A
Address
588 Q Block, Johar Town, Lahore, PB, PAK
Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its departments include Active Pharma Ingredients (API) and Formulations. Some of its products include Askprol C Tab, Lenon Tab, Recoz Tab, Cingol Tab among others.

Citi Pharma Headlines

No Headlines